Brain aneurysm device study halted early

NCT ID NCT04391803

Terminated Disease control Sponsor: Medtronic Neurovascular Clinical Affairs Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a device called the Pipeline Flex Embolization Device with Shield Technology to treat ruptured brain aneurysms that are hard to fix with surgery or coils. The goal was to see if it could safely block the aneurysm and prevent rebleeding. The study was stopped early, and only 25 people were enrolled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired aneurysmal subarachnoid hemorrhage Aneurysm, Ruptured brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL ANEURYSM RUPTURED ANEURYSM

Contacts and locations

Locations

Geisinger Medical Center

Danville, Pennsylvania, 17822, United States
Rush University Medical Center

Chicago, Illinois, 60612, United States
Semmes Murphey Clinic

Memphis, Tennessee, 38120, United States
Stony Brook University Hospital

Stony Brook, New York, 11794, United States
University of Kentucky Albert B Chandler Hospital

Lexington, Kentucky, 40506, United States
Wellstar Kennestone Hospital

Marietta, Georgia, 30060, United States
Yale New Haven Hospital

New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.